Gastrointestinal Cancers and Clinical Trials: What Patients Need to Know Earlier On - Takeaways - MDSpire

Gastrointestinal Cancers and Clinical Trials: What Patients Need to Know Earlier On

Breakthrough treatments for gastrointestinal cancers are being tested in clinical trials right now.

  • By

  • May 20, 2026

  • 9 min

Share

  • 1

    Patients should consult about clinical trial options before starting treatment for gastrointestinal cancers to avoid missing opportunities.

  • 2

    USC Norris Comprehensive Cancer Center offers over 50 clinical trials for various gastrointestinal malignancies, including phase 1 to phase 3 studies.

  • 3

    Novel therapies, including immunotherapy and targeted treatments, are being tested in clinical trials, providing patients with advanced options.

  • 4

    Eligibility for clinical trials often requires patients to not have started standard treatment, emphasizing the importance of early consultation.

  • 5

    Common misconceptions about clinical trials include concerns about receiving suboptimal treatment or placebos, which are generally not the case.

Original Source(s)

Gastrointestinal Cancers and Clinical Trials: What Patients Need to Know Earlier On

  • by

  • May 20, 2026

Related Content

Turning Medical Insights into Patient Impact

Veeva research reveals a stark gap between the insights biopharma captures and the actions it takes – highlighting a missed opportunity to improve patient outcomes

Rethinking Progress in Clinical Trials

Three clinical development leaders discuss how early signals, trial design, regulatory expectations, and patient access are reshaping clinical development

  • May 20, 2026

  • 11 min
Roswell Park Experts Report on Discovery of Rare Bladder Cells, Neural Mapping of Pelvic Floor Muscles at AUA 2026

Evidence provided by a Roswell Park study indicates that neoadjuvant chemotherapy may be the preferred course of treatment for patients with non-muscle-invasive bladder cancer (NMIBC) when their disease progresses and they are diagnosed with muscle-invasive bladder cancer (MIBC)

  • by

  • May 19, 2026

  • 7 min